New entries, price hikes spur changes among the 20 most expensive drugs — though not the kind politicians like to see
No matter how hard politicians in Washington DC pound on pharma companies for setting astronomical drug prices, they can’t seem to change one thing: The most expensive keep getting more expensive.
List prices for the most costly therapies, of course, is not fully representative of all prescription drugs for a variety of reasons, not the least because patients almost never end up paying that full amount — a fact the biopharma world likes to highlight. But the update on GoodRx’s running list of the 20 most expensive drugs in the US is still illustrative of the unabating trend of megapricing.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 157,400+ biopharma pros reading Endpoints daily — and it's free.